Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Jul 6;101(27):10006-11.
doi: 10.1073/pnas.0403459101. Epub 2004 Jun 28.

The bioactive Taxol conformation on beta-tubulin: experimental evidence from highly active constrained analogs

Affiliations

The bioactive Taxol conformation on beta-tubulin: experimental evidence from highly active constrained analogs

Thota Ganesh et al. Proc Natl Acad Sci U S A. .

Abstract

The important anticancer drug Taxol (paclitaxel) binds to tubulin in a stoichiometric ratio and promotes its assembly into microtubules. The conformation of microtubule-bound drug has been the subject of intense study, and various suggestions have been made. In this work we present experimental and theoretical evidence that Taxol adopts a T-shaped conformation when it is bound to tubulin.

PubMed Disclaimer

Figures

Scheme 1.
Scheme 1.
Structures of Taxol (1a), docetaxel (1b), discodermolide (2), epothilone B (3), and eleutherobin (4).
Fig. 1.
Fig. 1.
Synthetic scheme for the bridged paclitaxels 13a, 13b, 14a, and 14b. The reagents and conditions for the “a” series of β-lactams were similar to those below for the “b” series. Reagents and conditions for the “b” series β-lactams follow. i, 5b, p-MeOC6H4NH2, MgSO4, CH2Cl2, 100%. ii, CH3COOCH2COCl, Et3N, -78°C to room temperature (rt), 12 h, 85%. iii, Lipase (Amano PS), phosphate buffer, pH 7.2, CH3CN, 24 h, 98%. iv, 1M KOH, THF, 0°C, 100%. v, TIPSCl, imidazole, DMF, 94%. vi, CAN, CH3CN, -5°C, 62%. vii, PhCOCl, Et3N, DMAP, CH2Cl2, 95%. viii, LiHMDS, THF, 0°C, CH2—CHCOCl, 52%. ix, HF-pyridine, THF, 70%. x, CeCl3,Ac2O, THF, 96%. xi, Et3SiCl, imidazole, DCM, 72%. xii, 8a, NaH, THF, 0°C to rt, 24 h. xiii, (H2IMes)(PCy3)(CI)2Ru—CHPh, CH2Cl2, 3 h. xiv, HF-pyridine, 12 h. xv, H2,Pd/C(10%), 35 psi, 2.5 h. xvi, 8b, NaH, THF, 0°C to rt, 24 h, 50%. xvii, HF-Pyridine, THF, 81%. xviii, (H2IMes)(PCy3)(CI)2Ru—CHPh, CH2Cl2, 3 h, 64%. xix, HF-pyridine, 12 h, 98%. xx, H2, Pd/C(10%), 35 psi, 2.5 h, 96%.
Scheme 2.
Scheme 2.
Structure of the fluorescent Taxol derivative N-AB-PT (15).
Fig. 3.
Fig. 3.
Competition displacement of fluorescent Taxol 15 from tubulin by Taxol (black dots) and by compound 13b (red dots). Compound 15 was maintained at 5 μM, and increasing amounts of Taxol or compound 13b were added.
Fig. 2.
Fig. 2.
T-Taxol conformation. (a) The similar and extended ring-to-ring distances between the C-2 benzoyl phenyl and the C-3′ phenyl and benzamido phenyl centers, respectively. (b) H—H separations between the C-4 acetate methyl group and the ortho and meta postions of the C-3′ phenyl ring.
Scheme 3.
Scheme 3.
Structure of bridged Taxol 16.
Fig. 4.
Fig. 4.
NAMFIS-derived T-conformations for 13b (76% red, 7% green) superimposed on the tubulin-bound T-Taxol form (blue).
Fig. 5.
Fig. 5.
T-Taxol (blue) bound to β-tubulin as described in ref. . The ortho-bridged T-form of 13b (red, both ligand and protein binding site subjected to MD relaxation similar to T-Taxol) superimposed on Taxol avoids the steric contact with Phe-270 at the bottom of the hydrophobic taxoid pocket experienced by the meta-bridged analog 16 (27).
Fig. 6.
Fig. 6.
A view of ortho-bridged 13b in which phenyl rings emanating from C-2 and C-3′ surround the imidazole of His-227 in a sandwich motif; the C-4 OAc to C-3′ phenyl bridge (yellow) avoids the latter while stabilizing the T-Taxol conformation.

References

    1. Crown, J. & O'Leary, M. (2000) Lancet 355, 1176-1178. - PubMed
    1. Nabholtz, J.-M., Tonkin, K., Smylie, M., Au, H.-J., Lindsay, M.-A. & Mackey, J. (2000) Exp. Opin. Pharmacother. 1, 187-206. - PubMed
    1. Miller, K. D. & Sledge, G. W., Jr. (1999) Cancer Invest. 17, 121-136. - PubMed
    1. Schiff, P. B., Fant, J. & Horwitz, S. B. (1979) Nature 277, 665-667. - PubMed
    1. Ringel, I. & Horwitz, S. B. (1991) J. Natl. Cancer Inst. 83, 288-291. - PubMed

Publication types

LinkOut - more resources